amyndas.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.amyndas.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Home – Amyndas
Description Amyndas is a pharmaceutical company developing potent complement therapeutics for inflammatory diseases and disorders based on its patented technology for modulating the complement
Keywords N/A
Server Information
WebSite amyndas faviconamyndas.com
Host IP 34.69.142.169
Location United States
Related Websites
Site Rank
More to Explore
amyndas.com Valuation
US$2,451,002
Last updated: 2023-05-14 11:36:20

amyndas.com has Semrush global rank of 4,318,358. amyndas.com has an estimated worth of US$ 2,451,002, based on its estimated Ads revenue. amyndas.com receives approximately 282,808 unique visitors each day. Its web server is located in United States, with IP address 34.69.142.169. According to SiteAdvisor, amyndas.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,451,002
Daily Ads Revenue US$2,263
Monthly Ads Revenue US$67,874
Yearly Ads Revenue US$814,487
Daily Unique Visitors 18,854
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
amyndas.com. A 600 IP: 34.69.142.169
amyndas.com. NS 3600 NS Record: ns24.domaincontrol.com.
amyndas.com. NS 3600 NS Record: ns23.domaincontrol.com.
amyndas.com. MX 3600 MX Record: 10 mx1-us1.ppe-hosted.com.
amyndas.com. MX 3600 MX Record: 20 mx2-us1.ppe-hosted.com.
amyndas.com. TXT 3600 TXT Record: MS=ms75435522
amyndas.com. TXT 3600 TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-14 11:36:20
Home About What We Do Founder’s Bio Management Research & Development Our Focus Our Pipeline Clinical Trials Technology Selected Publications Notes on Targeted Conditions News Contact Us LinkedIn Twitter Home About What We Do Founder’s Bio Management Research & Development Our Focus Our Pipeline Clinical Trials Technology Selected Publications Notes on Targeted Conditions News Contact Us LinkedIn Twitter The Next Generation of Complement Therapeutics Amyndas is a pharmaceutical company developing potent complement therapeutics for inflammatory diseases and disorders based on its patented technology for modulating the complement system. Research Focus Read about our priority clinical programs Technology Learn more about our compound development Publications Find links to relevant scientific papers and reviews Copyright © 2023 - Amyndas Pharmaceuticals. All Rights
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Thu, 23 Dec 2021 08:39:31 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://amyndas.com/
Host-Header: 8441280b0c35cbc1147f8ba998a563a7
X-HTTPS-Enforce: 1
X-Proxy-Cache-Info: DT:1

HTTP/2 301 
server: nginx
date: Thu, 23 Dec 2021 08:39:31 GMT
content-type: text/html; charset=iso-8859-1
location: https://www.amyndas.com/
content-security-policy: upgrade-insecure-requests
cache-control: max-age=3600
expires: Thu, 23 Dec 2021 09:39:31 GMT
host-header: 8441280b0c35cbc1147f8ba998a563a7
x-proxy-cache-info: DT:1

HTTP/2 200 
date: Thu, 23 Dec 2021 08:39:31 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-cache-enabled: True
x-pingback: https://www.amyndas.com/xmlrpc.php
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
content-security-policy: upgrade-insecure-requests
cache-control: max-age=3600
expires: Thu, 23 Dec 2021 09:39:31 GMT
x-httpd: 1
host-header: 8441280b0c35cbc1147f8ba998a563a7
x-proxy-cache-info: DT:1
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=vqOPVi3g185mmPW%2F6q%2Fvd0fgbiNKPpvaB0Va0cShqzAZjGaYLgh7%2FVUZx%2BdIurDhu%2BHA03xmnmmpgqhZXU%2BwNxm%2BFv4xLKQUtPrEELTmYSJKzkc3ga7NYr5hcLOpejrybhA%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6c2047a64ed38c8a-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
amyndas.com Whois Information
Domain Name: AMYNDAS.COM
Registry Domain ID: 1716292945_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-04-27T18:11:38Z
Creation Date: 2012-04-27T00:29:13Z
Registry Expiry Date: 2022-04-27T00:29:13Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS23.DOMAINCONTROL.COM
Name Server: NS24.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-26T07:46:51Z <<<

Copyright © 2022 WebZZ.US 0.0249